These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 126059)

  • 21. Neocarzinostatin-induced complete regression of metastatic renal cell carcinoma.
    Satake I; Tari K; Yamamoto M; Nishimura H
    J Urol; 1985 Jan; 133(1):87-9. PubMed ID: 3155476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimetastatic and antitumor activity of a derivative of neocarzinostatin: an organic solvent- and water-soluble polymer-conjugated protein.
    Maeda H; Takeshita J; Kanamaru R; Sato H; Khatoh J; Sato H
    Gan; 1979 Oct; 70(5):601-6. PubMed ID: 160353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized phase II study of m-AMSA (NSC 249992) and neocarzinostatin (NSC 157365) in non-small cell bronchogenic carcinoma. An Eastern Cooperative Group Study.
    Ettinger DS; Day R; Ferraro JA; Ruckdeschel JC; Woll JE; Creech RH; Vogl SE
    Am J Clin Oncol; 1983 Apr; 6(2):167-70. PubMed ID: 6299093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Reinduction chemotherapy of acute leukemia with neocarzinostatin and other conventional antileukemic agents (author's transl)].
    Nagao T; Kammura O; Nozaki H; Takahashi Y; Niiya K
    Rinsho Ketsueki; 1976 Aug; 17(8):838-43. PubMed ID: 144198
    [No Abstract]   [Full Text] [Related]  

  • 25. Neocarzinostatin: A new chemotherapeutic approach to acute leukemia.
    Kitajima K; Kamimura O; Hiraki K
    Nihon Ketsueki Gakkai Zasshi; 1974 Jun; 37(3):316-23. PubMed ID: 4479922
    [No Abstract]   [Full Text] [Related]  

  • 26. Phase I study with neocarzinostatin: tolerance to two hour infusion and continuous infusion.
    Ohnuma T; Nogeire C; Cuttner J; Holland JF
    Cancer; 1978 Oct; 42(4):1670-9. PubMed ID: 152143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Neocarzinostatin. A new chemotherapeutic approach to acute leukemia (author's transl)].
    Hiraki K; Kamimura O; Takahashi I; Nagao T; Kitajima K; Irino S
    Nouv Rev Fr Hematol; 1973; 13(4):445-51. PubMed ID: 4271094
    [No Abstract]   [Full Text] [Related]  

  • 28. Phase I study of neocarzinostatin in children with cancer.
    Rivera G; Howarth C; Aur RJ; Pratt CB
    Cancer Treat Rep; 1978 Dec; 62(12):2105-7. PubMed ID: 156067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neocarzinostatin (NSC 157365) a new cancerostatic compound.
    Legha SS; Von Hoff DD; Rozencweig M; Abraham D; Slavik M; Muggia M
    Oncology; 1976; 33(5-6):265-70. PubMed ID: 141012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zinostatin and doxorubicin. A combination phase I study.
    Issell BF; Ginsberg SJ; Comis RL
    Cancer Clin Trials; 1981; 4(3):323-6. PubMed ID: 6269771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Reductive effect on ascites, of neocarzinostatin in patients with ovarian cancer].
    Takahashi K; Watanabe M; Kikuchi J; Kishi H; Saito K; Mouri H; Ikeno N; Endo H; Shima I; Morizuka T
    Gan To Kagaku Ryoho; 1988 May; 15(5):1777-81. PubMed ID: 2967052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A phase II study of neocarzinostatin (NSC 157365) in malignant hepatoma. An Eastern Cooperative Oncology Group pilot study.
    Falkson G; Von Hoff D; Klaassen D; Du Plessis H; Van Der Merwe CF; Van Der Merwe AM; Carbone PP
    Cancer Chemother Pharmacol; 1980; 4(1):33-6. PubMed ID: 6244904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Modern tactics in therapy of acute leukemia].
    Fainshtein FE; Kovaleva IG; Isaev VG; Abakumov EM
    Ter Arkh; 1972 Nov; 44(11):3-10. PubMed ID: 4666028
    [No Abstract]   [Full Text] [Related]  

  • 34. [Preliminary results of a cooperative clinical study of the new antitumor antibiotic, carminomycin].
    Borisov VI; Lipatov AM; Perevodchikova NI; Alekseev NA; Vygovskaia IaI
    Antibiotiki; 1976 Nov; 21(11):1026-30. PubMed ID: 798543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent advances in antitumor antibiotics.
    Umezawa H
    Antibiot Chemother (1971); 1978; 23():76-87. PubMed ID: 77145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Neocarzinostatin: molecular mechanism of action and prospects for clinical use].
    Köhnlein W; Jung G
    Arzneimittelforschung; 1982; 32(11):1474-9. PubMed ID: 6217819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA repair in human leukemic leucocytes treated with neocarzinostatin.
    Sasada M; Sawada H; Nakamura T; Uchino H
    Gan; 1978 Jun; 69(3):407-12. PubMed ID: 149685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The treatment of acute leukemia with continuous infusion L-Alanosine.
    Weick JK; Tranum BL; Morrison FS
    Invest New Drugs; 1983; 1(3):249-51. PubMed ID: 6678874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Principles of modern therapy in acute leukemias].
    Orzechowska-Juzwenko K
    Pol Arch Med Wewn; 1976 Jan; 55(1):57-70. PubMed ID: 765974
    [No Abstract]   [Full Text] [Related]  

  • 40. Zinostatin-related pulmonary toxicity.
    Calvo DB; Legha SS; McKelvey EM; Bodey GP; Dail DH
    Cancer Treat Rep; 1981; 65(1-2):165-7. PubMed ID: 6452946
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.